Impact of COVID-19 on leprosy reactions and of leprosy treatments on COVID-19 severity
- PMID: 36331835
- DOI: 10.25259/IJDVL_1235_2021
Impact of COVID-19 on leprosy reactions and of leprosy treatments on COVID-19 severity
Comment on
-
The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study.PLoS Negl Trop Dis. 2021 Jul 28;15(7):e0009635. doi: 10.1371/journal.pntd.0009635. eCollection 2021 Jul. PLoS Negl Trop Dis. 2021. PMID: 34319982 Free PMC article.
References
-
- Antunes DE, Goulart IMB, Goulart LR,. Will cases of leprosy reaction increase with COVID-19 infection?. PLoS Negl Trop Dis. 2020; 14:e0008460
-
- Li Y, Shi K, Qi F, Yu Z, Chen C, Pan J, et al. Thalidomide combined with short-term low-dose glucocorticoid therapy for the treatment of severe COVID-19: A case-series study. Int J Infect Dis. 2021; 103:507-13
-
- Cerqueira SRPS, Deps PD, Cunha DV, Bezerra NVF, Barroso DH, Pinheiro ABS, et al. The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study. PLoS Negl Trop Dis. 2021; 15:e0009635
-
- Andrade PR, Jardim MR, da Silva AC, Manhaes PS, Antunes SL, Vital R, et al. Inflammatory cytokines are involved in focal demyelination in leprosy neuritis. J Neuropathol Exp Neurol. 2016; 75:272-83
-
- Arunthathi S, Satheesh KK,. Does clofazimine have a prophylactic role against neuritis?. Lepr Rev. 1997; 68:233-41
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
